Evidence map›Paper›PMID 33768354›Full record

ReviewArchives of toxicology2021

Origins, fate, and actions of methylated trivalent metabolites of inorganic arsenic: progress and prospects.

Miroslav Stýblo, Abhishek Venkatratnam, Rebecca C Fry, David J Thomas

Open access · greenAbstract readReview
In one paragraph

Review in Archives of toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Chronic arsenic exposure affects stromal cells and signaling in the small intestine in a sex-specific manner.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Miroslav StýbloDepartment of Nutrition, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. styblo@med.unc.edu.ORCID http://orcid.org/0000-0001-6764-1900
Abhishek VenkatratnamDepartment of Nutrition, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Rebecca C FryDepartment of Environmental Science and Engineering, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
David J ThomasChemical Characterization and Exposure Division, Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, 27709, USA. Thomas.David@epa.gov.
University of North Carolina at Chapel Hill · USEnvironmental Protection Agency · US

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Hazel B Nichols · 2001 to 2026
$36.3M
The UNC Chapel Hill Superfund Research Program (UNC-SRP)P42ES031007 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kathleen M Gray · 2020 to 2026
$22.2M
Environmental Arsenic and Diabetes MellitusR01ES015326 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STYBLO, MIROSLAV · 2008 to 2012
$3.4M
Genetic underpinning of diabetes associated with arsenic exposureR01ES029925 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRY, REBECCA, PARDO-MANUEL DE VILLENA, FERNANDO · 2019 to 2023
$3.3M
Developmental windows for arsenic-associated diabetesR01ES028721 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRY, REBECCA, STYBLO, MIROSLAV · 2018 to 2022
$2.2M
Humanized mouse models for arsenic toxicologyR01ES032643 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KOLLER, BEVERLY H, STYBLO, MIROSLAV · 2021 to 2025
$2.1M
Mechanisms of Arsenic-Induced Diabetes Mellitus - Administrative SupplementR01ES022697 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STYBLO, MIROSLAV · 2014 to 2017
$1.5M
The Role of Diet in Diabetes Associated with Arsenic ExposureR21ES023690 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MENDEZ, MICHELLE A, STYBLO, MIROSLAV · 2014 to 2015
$409k
National Institute of Environmental Health Sciences (US) P42ES031007NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P42 ES031007NIEHS NIH HHS R01 ES015326NIEHS NIH HHS R01 ES022697NIEHS NIH HHS R01 ES028721NIEHS NIH HHS R01ES028721NIEHS NIH HHS R01 ES029925NIEHS NIH HHS R01 ES032643NIEHS NIH HHS R21 ES023690
6 · The paper itself

Abstract

The toxic metalloid inorganic arsenic (iAs) is widely distributed in the environment. Chronic exposure to iAs from environmental sources has been linked to a variety of human diseases. Methylation of iAs is the primary pathway for metabolism of iAs. In humans, methylation of iAs is catalyzed by arsenic (+ 3 oxidation state) methyltransferase (AS3MT). Conversion of iAs to mono- and di-methylated species (MAs and DMAs) detoxifies iAs by increasing the rate of whole body clearance of arsenic. Interindividual differences in iAs metabolism play key roles in pathogenesis of and susceptibility to a range of disease outcomes associated with iAs exposure. These adverse health effects are in part associated with the production of methylated trivalent arsenic species, methylarsonous acid (MAs

Indexed as

ArsenicArsenicalsCacodylic AcidCells, CulturedHumansMethylationMethyltransferasesOxidation-ReductionArsenicArsenicalsAS3MT protein, humanCacodylic Aciddimethylarsinous acidMethyltransferasesmonomethylarsonic acidAnalysisArsenicDimethylarsinous acidMetabolismMethylarsonous acidToxicity

Identifiers

PMID33768354
PMCPMC8728880
OpenAlexW3139287456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.